Considering the potential for a large number of Lipitor lawsuit filings, it appears the JPML’s decision was warranted.
New York, New York (PRWEB) February 19, 2014
Dozens of federally-filed Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the statin drug caused patients to develop Type 2 diabetes have been consolidated in a multidistrict litigation and transferred to the U.S. District Court, District of South Carolina, for pretrial proceedings. According to an Order issued by the U.S. Judicial Panel for Multidistrict Litigation (JPML) on February 18, 2014, the new multidistrict litigation will consist of 56 product liability claims that allege a connection between Lipitor and diabetes. However, the Order noted that as many as 170 tag-along actions could also be transferred to the proceeding. In addition, all Lipitor lawsuits involving diabetes allegations that are filed in federal courts in the future will likely be transferred to the District of South Carolina. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))
“We continue to hear from individuals who have allegedly developed Type 2 diabetes due to their use of Lipitor. Considering the potential for a large number of Lipitor lawsuit filings, it appears the JPML’s decision was warranted,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have developed Type 2 diabetes due to the use of this statin medication.
Lipitor Diabetes Allegations
According to court documents, all of the Lipitor lawsuits pending in the newly established litigation claim that patients developed Type 2 diabetes as a result of taking the medication. Plaintiffs further allege that Pfizer Inc. failed to adequately warn patients and doctors about the link between Lipitor and diabetes, and was negligent, careless and/or reckless in its marketing of the cholesterol-lowering drug. The establishment of the multidistrict litigation for Lipitor diabetes claims will allow these lawsuits to undergo coordinated pretrial proceedings, which will eliminate duplicative discovery, inconsistent court rulings, and preserve the resources of the court, parties and witnesses.
Lipitor lawsuits have been mounting since February 2012, when the U.S. Food & Drug Administration (FDA) ordered the manufacturers of statin drugs to add new warnings to their labels regarding their effects on blood sugar levels. The FDA action followed the publication of a study the prior month in JAMA: Internal Medicine, which reported that post-menopausal women treated with drugs like Lipitor were at increased risk of developing new-onset Type 2 diabetes. *
This past May, the British Medical Journal also reported an association between Lipitor and diabetes, finding that patients who took the drug had a 22 percent increased risk of new-onset diabetes.**
Individuals who allegedly developed diabetes due to their use of Lipitor may be entitled to compensation from Pfizer, Inc. Learn more about filing a Lipitor lawsuit at Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.
*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
**bmj.com/content/346/bmj.f2610, BMJ, May 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com